Drug Pipeline

Atumelnant Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
2
Phase 3
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT07144163
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia		 Trial sites expanded: 36 -> 45 locations
2026-05-16 NCT07144163
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia		 Trial sites expanded: 26 -> 36 locations
Active Studies by Phase
Phase 3
1
Phase 2/3
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07144163 A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia Congenital Adrenal Hyperplasia Recruiting
Phase 2/3
NCT07159841 A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH) Congenital Adrenal Hyperplasia Recruiting
Phase 1/2
NCT05804669 A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome Cushing Syndrome Recruiting
Phase 1
NCT07570082 Drug-Drug Interaction Study of Atumelnant in Healthy Participants Healthy Volunteers Recruiting
Sponsors Running Atumelnant Trials
Crinetics Pharmaceuticals Inc. (4)
Get alerts when Atumelnant trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free